Eli Lilly: Losing Weight, Gaining Expectations

Eli Lilly's weight loss drug, Semaglutide, is gaining market share and expectations, driving the company's growth.

Want to stay up to date with the world events at sea or at home?

Explore Navvyx News - the best News app for seafarers.